Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0112857 Extended Release Aspirin
The present invention is directed to methods of inhibiting platelet aggregation, reducing serum thromboxane B2 levels, reducing systemic or cardiovascular...
2017/0112856 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER
A pharmaceutical composition for treating cancer in an individual, comprising at least a pharmaceutically effective amount of a novel target HCC reversal...
2017/0112855 NOVEL THERAPEUTIC COMPOSITION
A composition comprising a tetrahydrocannabinoid compound, a second cannabinoid and a corticosteroid is provided. The composition is useful to treat psoriasis...
2017/0112854 Misoprostol Composition
The present invention relates to the use of misoprostol for the induction of labour in a pregnant female, and in particular to the use of a sustained delivery...
2017/0112853 Hypotensive Lipid And Timolol Compositions And Methods Of Using Same
New compositions for and methods of treating ocular hypertension provide for effective treatment of ocular hypertension often using reduced concentrations of...
2017/0112852 DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM)
The invention relates to a dosing regimen for sedation with the fast-acting benzodiazepine CNS 7056 in combination with an opioid, in particular fentanyl,...
2017/0112851 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL
The present invention relates to tricyclic hexahydrodiazepinoquinolines carrying a substituted alkyl radical, to a method for producing them, to a...
2017/0112850 Pharmaceutical Composition Comprising Licarbazepine Acetate
A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a...
2017/0112849 Method of Treatment Using Substituted Imidazo[1,2b]Pyridazine Compounds
Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic...
2017/0112848 THERAMUTEIN MODULATORS
This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of...
2017/0112847 EMULSION FORMULATIONS OF APREPITANT
Disclosed herein are novel pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. Also included...
2017/0112846 OXYGEN LINKED PYRIMIDINE DERIVATIVES
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen...
2017/0112845 sGC STIMULATORS
Compounds of Formula IA and Formula IB are described. They are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These...
2017/0112844 Benzimidazole Derivatives As PI3 Kinase Inhibitors
This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide...
2017/0112842 MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS
Compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein ring A, ring B, W, m, D, R.sup.2, R.sup.2a, R.sup.3, R.sup.3a, and Z are as...
2017/0112841 THERAPIES FOR HEMATOLOGIC MALIGNANCIES
The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In...
2017/0112840 HETEROCYCLYL COMPOUNDS
The present invention is related to heteroaryl compounds as MEK inhibitors. The invention includes heteroaryl compounds of formula I, their tautomers and...
2017/0112839 NEW TREATMENT
The invention provides a compound for use in treating or preventing a disease or condition selected from cystic fibrosis, chronic obstructive pulmonary disease...
2017/0112838 USE OF PEMIROLAST
According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast,...
2017/0112837 USE OF PEMIROLAST
According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast,...
2017/0112836 SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS
The present invention relates to solid pharmaceutical compositions comprising biopterin derivatives as well as methods for obtaining such solid pharmaceutical...
2017/0112835 QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES
The present invention relates to the use of quinazolines of formula (I), ##STR00001## wherein the groups R.sup.a to R.sup.d have the meanings given in the claims...
2017/0112834 CERITINIB FORMULATION
The present disclosure relates to a new pharmaceutical composition comprising Ceritinib. Particularly it is directed to the tablet that is prepared by wet...
2017/0112833 Tyrosine Kinase Inhibitor And Uses Thereof
Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, or their stereoisomers, which can be used as tyrosine...
2017/0112831 USE OF CCR1 ANTAGONISTS AS A TREATMENT FOR TUMORS OF THE CENTRAL NERVOUS SYSTEM
The present disclosure relates to Chemotactic Cytokine Receptor 1 (CCR1) antagonists and their use in the treatment of tumors of the central nervous system....
2017/0112830 SUSPENSION AND CAKE COMPOSITION CONTAINING CARBOSTYRYL DERIVATIVE AND SILICONE OIL AND/OR SILICONE OIL DERIVATIVE
A suspension and a cake composition are provided in which agglomeration of the active ingredient that is caused when silicone oil and/or silicone oil...
2017/0112829 USE OF COMPOUNDS BINDING TO THE SIGMA RECEPTOR LIGANDS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A...
The present invention refers to the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from...
2017/0112828 PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE
The invention concerns a storage stable pharmaceutical preparation comprising oxycodone and naloxone for use in pain therapy, with the active compounds being...
2017/0112827 Morphinan Derivatives with High Oral Bioavailability
The instant application relates to morphinan derivatives of formula I with enhanced oral bioavailability for the treatment of diseases associated with opioid...
2017/0112826 OLIGOMER-OPIOID AGONIST CONJUGATES
The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when ...
2017/0112825 METHODS AND COMPOSITIONS FOR REGULATING CONVERSION OF A PRODRUG TO AN ACTIVE PHARMACEUTICAL INGREDIENT
An abuse deterrent pharmaceutical composition including an abuse deterrent pharmaceutical composition including a prodrug of a pharmaceutically active...
2017/0112824 COMBINATION THERAPIES FOR THE TREATMENT OF FUNGAL INFECTIONS
Methods and pharmaceutical compositions for treating fungal infections in a patient via administration of hydroxyurea and an ergosterol synthesis inhibitor,...
2017/0112823 COMPOSITIONS AND METHODS TO TREAT NEUROPATHY AND RELATED CONDITIONS
In various embodiments, the invention relates to compositions and methods for treating a condition associated with inflammation. In some embodiments the...
2017/0112822 METHODS FOR TREATING PARKINSON'S DISEASE
An oromucosal solution comprising about 1-8% (w/v) apomorphine or a pharmaceutical acceptable salt thereof solubilised in a non-aqueous carrier containing at...
2017/0112821 Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
The present invention is directed to multi-tyrosine kinase inhibitor compounds. The present invention is further directed to compositions comprising those...
2017/0112820 METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
Methods for the treatment of CNS disorders using combinations of muscarinic activators and inhibitors, and medicaments comprising muscarinic activators and...
2017/0112819 METHODS FOR TREATING MULTIPLE MYELOMA WITH 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE...
Methods of treating, preventing and/or managing cancer as well as and diseases and disorder associated with, or characterized by, undesired angiogenesis are...
2017/0112818 INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising...
2017/0112817 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCLE WEAKNESS-RELATED DISEASES, CONTAINING...
The present invention relates to A method for promoting the differentiation of myoblasts comprising treating myoblasts with butylpyridinium, a derivative...
2017/0112816 CYCLOPROPYLAMINES AS LSD1 INHIBITORS
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
2017/0112815 BETAHISTINE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
Disclosed herein are method of treating neurodegenerative diseases, including Alzheimer's disease, with the anti-histaminic drug betahistine.
2017/0112814 AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, ##STR00001## wherein X is CH.sub.2 or a single bond; Y is a group of formula ...
2017/0112813 METHODS OF TREATING AUTOPHAGY-ASSOCIATED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS,...
The invention provides methods of treating autophagy mediated diseases and disorders and related pharmaceutical compositions, diagnostics, screening techniques...
2017/0112812 HYDANTOIN DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION
The present invention provides pharmaceutical compositions for inducing bone and/or cartilage anabolism, which comprises as an active ingredient a compound...
2017/0112811 THERAPEUTIC AGENT FOR DYSLIPIDEMIA
The present invention addresses the problem of providing a pharmaceutical combination composition and drug combinations for the prevention and/or treatment of...
2017/0112809 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER
The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment...
2017/0112808 USES OF COMPOUNDS AND MIXTURES FROM ANTRODIA CINNAMOMEA MYCELIA
The present invention relates to novel uses of compounds from Antrodia cinnamomea mycelia and mixtures comprising the compounds. The novel uses comprise...
2017/0112807 COMBINATION CHEMOTHERAPY COMPRISING A LIPOSOMAL PRODRUG OF MITOMYCIN C
The present invention is based on a finding of an unexpected synergistic and safe combination of antineoplastic agents which when administered in combination...
2017/0112806 PHARMACEUTICAL FORMULATIONS
The present invention relates to formulations including compounds of Formula (I), ##STR00001## or prodrug, or a pharmaceutically acceptable salt thereof.
2017/0112805 BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS
The present invention relates to compounds of formula I: ##STR00001## in which n, m, X, Y.sub.1, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are defined in...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.